Skip to main content
Erschienen in: Social Psychiatry and Psychiatric Epidemiology 8/2013

01.08.2013 | Original Paper

Cancer mortality in patients with psychiatric diagnoses: a higher hazard of cancer death does not lead to a higher cumulative risk of dying from cancer

verfasst von: Ng Chong Guan, Fabian Termorshuizen, Wijnand Laan, Hugo M. Smeets, Nor Zuraida Zainal, René S. Kahn, Niek J. De Wit, Marco P. M. Boks

Erschienen in: Social Psychiatry and Psychiatric Epidemiology | Ausgabe 8/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Both increased as well as decreased cancer mortality among psychiatric patients has been reported, but competing death causes were not included in the analyses. This study aims to investigate whether observed cancer mortality in patients with psychiatric disorders might be biased by competing death causes.

Method

In this retrospective cohort study on data from the Psychiatric Case Register Middle Netherlands linked to the death register of Statistics Netherlands, the risk of cancer death among patients with schizophrenia (N = 4,590), bipolar disorder (N = 2,077), depression (N = 15,130) and their matched controls (N = 87,405) was analyzed using a competing risk model.

Results

Compared to controls, higher hazards of cancer death were found in patients with schizophrenia (HR = 1.61, 95 % CI 1.26–2.06), bipolar disorder (HR = 1.20, 95 % CI 0.81–1.79) and depression (HR = 1.26, 95 % CI 1.10–1.44). However, the HRs of death due to suicide and other death causes were more elevated. Consequently, among those who died, the 12-year cumulative risk of cancer death was significantly lower.

Conclusions

Our analysis shows that, compared to the general population, psychiatric patients are at higher risk of dying from cancer, provided that they survive the much more elevated risks of suicide and other death causes.
Literatur
1.
Zurück zum Zitat Commissioners in Lunacy for England and Wales (1909) Annual Report, HMSO, London Commissioners in Lunacy for England and Wales (1909) Annual Report, HMSO, London
2.
Zurück zum Zitat Mortensen PB (1989) The incidence of cancer in schizophrenic patients. J Epidemiol Commun Health 43:43–47CrossRef Mortensen PB (1989) The incidence of cancer in schizophrenic patients. J Epidemiol Commun Health 43:43–47CrossRef
3.
Zurück zum Zitat Goldacre MJ, Kurina LM, Wotton CJ, Yeates D, Seagroatt V (2005) Schizophrenia and cancer: an epidemiological study. Br J Psychiatry 187:334–338PubMedCrossRef Goldacre MJ, Kurina LM, Wotton CJ, Yeates D, Seagroatt V (2005) Schizophrenia and cancer: an epidemiological study. Br J Psychiatry 187:334–338PubMedCrossRef
4.
Zurück zum Zitat Tran E, Rouillon F, Loze JY, Casadebaig F, Phillippe A, Vitry F, Limosin F (2009) Cancer mortality in patients with schizophrenia. Cancer 115:3555–3562PubMedCrossRef Tran E, Rouillon F, Loze JY, Casadebaig F, Phillippe A, Vitry F, Limosin F (2009) Cancer mortality in patients with schizophrenia. Cancer 115:3555–3562PubMedCrossRef
5.
Zurück zum Zitat Hippisley-Cox J, Yinogradova Y, Coupland C, Parker C (2007) Risk of malignancy in patients with schizophrenia or bipolar disorder. Arch Gen Psychiatr 64:1368–1376PubMedCrossRef Hippisley-Cox J, Yinogradova Y, Coupland C, Parker C (2007) Risk of malignancy in patients with schizophrenia or bipolar disorder. Arch Gen Psychiatr 64:1368–1376PubMedCrossRef
6.
Zurück zum Zitat Saha S, Chant D, McGrath JA (2007) Systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 64:1123–1131PubMedCrossRef Saha S, Chant D, McGrath JA (2007) Systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 64:1123–1131PubMedCrossRef
7.
Zurück zum Zitat Hodgson R, Wildgust HJ, Bushe CJ (2010) Cancer and schizophrenia: is there a paradox? J Psychopharmacol 24(11):51–60PubMedCrossRef Hodgson R, Wildgust HJ, Bushe CJ (2010) Cancer and schizophrenia: is there a paradox? J Psychopharmacol 24(11):51–60PubMedCrossRef
8.
Zurück zum Zitat Hawton K, Harriss L, Zahl D (2006) Deaths from all causes in a long-term follow-up study of 11 583 deliberate self-harm patients. Psych Med 36:397–405CrossRef Hawton K, Harriss L, Zahl D (2006) Deaths from all causes in a long-term follow-up study of 11 583 deliberate self-harm patients. Psych Med 36:397–405CrossRef
9.
Zurück zum Zitat Carney CP, Jones LS (2006) Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. Psychosom Med 68:684–691PubMedCrossRef Carney CP, Jones LS (2006) Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. Psychosom Med 68:684–691PubMedCrossRef
10.
Zurück zum Zitat Barchana M, Levav I, Lipshitz I, Pugachova I, Kohn R, Wezman A, Grinshpoon A (2008) Enhanced cancer risk among patients with bipolar disorder. J Affect Disord 108:43–48PubMedCrossRef Barchana M, Levav I, Lipshitz I, Pugachova I, Kohn R, Wezman A, Grinshpoon A (2008) Enhanced cancer risk among patients with bipolar disorder. J Affect Disord 108:43–48PubMedCrossRef
11.
Zurück zum Zitat Oerlemans MEJ, van den Akker M, Schuurman AG, Kellen E, Buntinx F (2007) A meta-analysis on depression and subsequent cancer risk. Clin Pract Epidemiol Ment Health 3:29PubMedCrossRef Oerlemans MEJ, van den Akker M, Schuurman AG, Kellen E, Buntinx F (2007) A meta-analysis on depression and subsequent cancer risk. Clin Pract Epidemiol Ment Health 3:29PubMedCrossRef
12.
Zurück zum Zitat Dalton SO, Mellemkjaer L, Olsen JH, Mortensen PB, Johansen C (2002) Depression and cancer risk: a register-based study of patients hospitalized with affective disorders, Denmark, 1969–1993. Am J Epidemiol 155(12):1088–1095PubMedCrossRef Dalton SO, Mellemkjaer L, Olsen JH, Mortensen PB, Johansen C (2002) Depression and cancer risk: a register-based study of patients hospitalized with affective disorders, Denmark, 1969–1993. Am J Epidemiol 155(12):1088–1095PubMedCrossRef
13.
Zurück zum Zitat Putter H, Fiocco M, Geskus RB (2006) Tutorial in biostatistics: competing risks and multi-state models. Stat Med 7(26):2389–2430 Putter H, Fiocco M, Geskus RB (2006) Tutorial in biostatistics: competing risks and multi-state models. Stat Med 7(26):2389–2430
14.
Zurück zum Zitat Koller MT, Stijnen T, Steyerberg EW, Lubson J (2008) Meta-analyses of chronic disease trials with competing causes of death may yield biased odds ratio. J Clin Epidemiol 61(4):365–372PubMedCrossRef Koller MT, Stijnen T, Steyerberg EW, Lubson J (2008) Meta-analyses of chronic disease trials with competing causes of death may yield biased odds ratio. J Clin Epidemiol 61(4):365–372PubMedCrossRef
15.
Zurück zum Zitat Smeets HM, Laan W, Engelhard IM, Boks MPM, Geerlings MI, de Wit NJ (2011) The psychiatric case register middle Netherlands. BMC Psychiatry 11:106PubMedCrossRef Smeets HM, Laan W, Engelhard IM, Boks MPM, Geerlings MI, de Wit NJ (2011) The psychiatric case register middle Netherlands. BMC Psychiatry 11:106PubMedCrossRef
16.
Zurück zum Zitat Laan W, Termorshuizen F, Smeets HM, Boks MP, de Wit NJ, Geerlings MI (2011) A comorbid anxiety disorder does not result in an excess risk of death among patients with a depressive disorder. J Affect Disord 135:284–291PubMedCrossRef Laan W, Termorshuizen F, Smeets HM, Boks MP, de Wit NJ, Geerlings MI (2011) A comorbid anxiety disorder does not result in an excess risk of death among patients with a depressive disorder. J Affect Disord 135:284–291PubMedCrossRef
17.
Zurück zum Zitat Coviello V, Bogess M (2004) Cumulative incidence estimation in the presence of competing risks. STATA J 4:103–112 Coviello V, Bogess M (2004) Cumulative incidence estimation in the presence of competing risks. STATA J 4:103–112
18.
Zurück zum Zitat Chou FH, Tsai KY, Su CY, Lee CC (2011) The incidence and relative risk factors for developing cancer among patients with schizophrenia: a nine-year follow-up study. Schizophr Res 129(2–3):97–103PubMedCrossRef Chou FH, Tsai KY, Su CY, Lee CC (2011) The incidence and relative risk factors for developing cancer among patients with schizophrenia: a nine-year follow-up study. Schizophr Res 129(2–3):97–103PubMedCrossRef
19.
Zurück zum Zitat Cohen ME, Dembling B, Schorling JB (2002) The association between schizophrenia and cancer: a population-based mortality study. Schizophr Res 57:139–146PubMedCrossRef Cohen ME, Dembling B, Schorling JB (2002) The association between schizophrenia and cancer: a population-based mortality study. Schizophr Res 57:139–146PubMedCrossRef
20.
Zurück zum Zitat Høyer EH, Mortensen PB, Olesen AV (2000) Mortality and causes of death in a total national sample of patients with affective disorders admitted for the first time between 1973 and 1993. Br J Psychiatry 176:76–82PubMedCrossRef Høyer EH, Mortensen PB, Olesen AV (2000) Mortality and causes of death in a total national sample of patients with affective disorders admitted for the first time between 1973 and 1993. Br J Psychiatry 176:76–82PubMedCrossRef
21.
Zurück zum Zitat Joukamaa M, Heliövaara M, Knekt P, Aromaa A, Raitasalo R, Lehtinen V (2001) Mental disorders and cause-specific mortality. Br J Psychiatry 179:498–502PubMedCrossRef Joukamaa M, Heliövaara M, Knekt P, Aromaa A, Raitasalo R, Lehtinen V (2001) Mental disorders and cause-specific mortality. Br J Psychiatry 179:498–502PubMedCrossRef
22.
Zurück zum Zitat Gross AL, Gallo JJ, Eaton WW (2010) Depression and cancer risk: 24 years of follow-up of the Baltimore Epidemiologic Catchment Area sample. Cancer Causes Control 21(2):191–199PubMedCrossRef Gross AL, Gallo JJ, Eaton WW (2010) Depression and cancer risk: 24 years of follow-up of the Baltimore Epidemiologic Catchment Area sample. Cancer Causes Control 21(2):191–199PubMedCrossRef
23.
Zurück zum Zitat Brown S, Birtwistle J, Roe L, Thompson C (1999) The unhealthy lifestyle of people with schizophrenia. Psychol Med 29:697–701PubMedCrossRef Brown S, Birtwistle J, Roe L, Thompson C (1999) The unhealthy lifestyle of people with schizophrenia. Psychol Med 29:697–701PubMedCrossRef
24.
Zurück zum Zitat Miech RA, Caspi A, Moffitt TE, Entner Wright BR, Silva PA (1999) Low socioeconomic status and mental disorders: a longitudinal study of selection and causation during young adulthood. AJS 104(4):1096–1131 Miech RA, Caspi A, Moffitt TE, Entner Wright BR, Silva PA (1999) Low socioeconomic status and mental disorders: a longitudinal study of selection and causation during young adulthood. AJS 104(4):1096–1131
25.
Zurück zum Zitat Bebbington P, Ramana R (1995) The epidemiology of bipolar affective disorder. Soc Psychiatry Psychiatr Epidemiol 30:279–292PubMedCrossRef Bebbington P, Ramana R (1995) The epidemiology of bipolar affective disorder. Soc Psychiatry Psychiatr Epidemiol 30:279–292PubMedCrossRef
26.
Zurück zum Zitat Tsuchiya KJ, Agerbo E, Byrne M, Mortensen PB (2004) Higher socio-economic status of parents may increase risk for bipolar disorder in the offspring. Psychol Med 34:787–793PubMedCrossRef Tsuchiya KJ, Agerbo E, Byrne M, Mortensen PB (2004) Higher socio-economic status of parents may increase risk for bipolar disorder in the offspring. Psychol Med 34:787–793PubMedCrossRef
27.
Zurück zum Zitat Meyer JM, Stahl SM (2009) The metabolic syndrome and schizophrenia. Acta Psychiatr Scand 119:4–14PubMedCrossRef Meyer JM, Stahl SM (2009) The metabolic syndrome and schizophrenia. Acta Psychiatr Scand 119:4–14PubMedCrossRef
28.
Zurück zum Zitat Steingart A, Cotterchio M, Kreiger N, Sloan M (2003) Antidepressant medication use and breast cancer risk: a case-control study. Int J Epidemiol 32:961–966PubMedCrossRef Steingart A, Cotterchio M, Kreiger N, Sloan M (2003) Antidepressant medication use and breast cancer risk: a case-control study. Int J Epidemiol 32:961–966PubMedCrossRef
29.
Zurück zum Zitat Coogan PF, Palmer JR, Strom BL, Rosenberg L (2005) Use of selective serotonin reuptake inhibitors and the risk of breast cancer. Am J Epidemiol 162:835–838PubMedCrossRef Coogan PF, Palmer JR, Strom BL, Rosenberg L (2005) Use of selective serotonin reuptake inhibitors and the risk of breast cancer. Am J Epidemiol 162:835–838PubMedCrossRef
30.
Zurück zum Zitat Carrillo JA, Benitez J (1999) Are antipsychotic drugs potentially chemopreventive agents for cancer? Eur J Clin Pharmacol 55:487–488PubMedCrossRef Carrillo JA, Benitez J (1999) Are antipsychotic drugs potentially chemopreventive agents for cancer? Eur J Clin Pharmacol 55:487–488PubMedCrossRef
31.
Zurück zum Zitat Park JK, Lee HJ, Kim JW et al (2004) Difference in p53 gene polymorphisms between Korean schizophrenia and lung cancer patients. Schizophr Res 67:71–74PubMedCrossRef Park JK, Lee HJ, Kim JW et al (2004) Difference in p53 gene polymorphisms between Korean schizophrenia and lung cancer patients. Schizophr Res 67:71–74PubMedCrossRef
32.
Zurück zum Zitat Mykletun A, Bjerkeset O, Dewey M, Prince M, Overland S, Stewart R (2007) Anxiety, depression, and cause-specific mortality: the HUNT study. Psychosom Med 69:323–331PubMedCrossRef Mykletun A, Bjerkeset O, Dewey M, Prince M, Overland S, Stewart R (2007) Anxiety, depression, and cause-specific mortality: the HUNT study. Psychosom Med 69:323–331PubMedCrossRef
33.
Zurück zum Zitat Ji J, Sundquist K, Ning Y, Kendler KS, Sundquist J, Chen X (2012) Incidence of cancer in patients with schizophrenia and their first-degree relatives: a population-based study in Sweden. Schizophr Bull. doi:10.1093/schbul/sbs065 Ji J, Sundquist K, Ning Y, Kendler KS, Sundquist J, Chen X (2012) Incidence of cancer in patients with schizophrenia and their first-degree relatives: a population-based study in Sweden. Schizophr Bull. doi:10.​1093/​schbul/​sbs065
34.
Zurück zum Zitat Chou FH, Tsai KY, Su CY, Lee CC (2011) The incidence and relative risk factors for developing cancer among patients with schizophrenia: a nine-year follow-up study. Schizophr Res 129:97–103PubMedCrossRef Chou FH, Tsai KY, Su CY, Lee CC (2011) The incidence and relative risk factors for developing cancer among patients with schizophrenia: a nine-year follow-up study. Schizophr Res 129:97–103PubMedCrossRef
35.
Zurück zum Zitat Goldacre MJ, Wotton CJ, Yeates D, Seagroatt V, Flint J (2007) Cancer in people with depression or anxiety: record-linkage study. Soc Psychiatry Psychiatr Epidemiol 42:683–689PubMedCrossRef Goldacre MJ, Wotton CJ, Yeates D, Seagroatt V, Flint J (2007) Cancer in people with depression or anxiety: record-linkage study. Soc Psychiatry Psychiatr Epidemiol 42:683–689PubMedCrossRef
36.
Zurück zum Zitat Mitchell AJ, Malone D, Doebbeling CC (2009) Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies. Br J Psychiatry 194:491–499PubMedCrossRef Mitchell AJ, Malone D, Doebbeling CC (2009) Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies. Br J Psychiatry 194:491–499PubMedCrossRef
38.
Zurück zum Zitat Bostwick JM, Pancratz VS (2000) Affective disorders and suicide risk: a reexamination. Am J Psychiatry 157:1925–1932PubMedCrossRef Bostwick JM, Pancratz VS (2000) Affective disorders and suicide risk: a reexamination. Am J Psychiatry 157:1925–1932PubMedCrossRef
39.
Zurück zum Zitat Palmer BA, Pankratz VS, Bostwick JM (2005) The lifetime risk of suicide in schizophrenia: a reexamination. Arch Gen Psychiatry 62:247–253PubMedCrossRef Palmer BA, Pankratz VS, Bostwick JM (2005) The lifetime risk of suicide in schizophrenia: a reexamination. Arch Gen Psychiatry 62:247–253PubMedCrossRef
Metadaten
Titel
Cancer mortality in patients with psychiatric diagnoses: a higher hazard of cancer death does not lead to a higher cumulative risk of dying from cancer
verfasst von
Ng Chong Guan
Fabian Termorshuizen
Wijnand Laan
Hugo M. Smeets
Nor Zuraida Zainal
René S. Kahn
Niek J. De Wit
Marco P. M. Boks
Publikationsdatum
01.08.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Social Psychiatry and Psychiatric Epidemiology / Ausgabe 8/2013
Print ISSN: 0933-7954
Elektronische ISSN: 1433-9285
DOI
https://doi.org/10.1007/s00127-012-0612-8

Weitere Artikel der Ausgabe 8/2013

Social Psychiatry and Psychiatric Epidemiology 8/2013 Zur Ausgabe

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.